-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4
المؤلفون: Flint AC, Mitchell DK, Angus SP, Smith AE, Bessler W, Jiang L, Mang H, Li X, Lu Q, Rodriguez B, Sandusky GE, Masters AR, Zhang C, Dang P, Koenig J, Johnson GL, Shen W, Liu J, Aggarwal A, Donoho GP, Willard MD, Bhagwat SV, Clapp DW, Rhodes SD
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 01; Vol. 30 (9), pp. 1992.
نوع المنشور: Published Erratum
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: PubMed not MEDLINE; MEDLINE
-
5دورية أكاديمية
المؤلفون: Flint AC; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Mitchell DK; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Angus SP; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana., Smith AE; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Bessler W; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Jiang L; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Mang H; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Li X; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Lu Q; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Rodriguez B; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Sandusky GE; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana., Masters AR; Clinical Pharmacology Analytical Core, Indiana University School of Medicine, Indianapolis, Indiana., Zhang C; Center for Computational Biology and Bioinformatics and Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana., Dang P; Center for Computational Biology and Bioinformatics and Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana., Koenig J; Medical Scientist Training Program, Indiana University School of Medicine, Indianapolis, Indiana., Johnson GL; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Shen W; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Liu J; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Aggarwal A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Donoho GP; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Willard MD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Bhagwat SV; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Clapp DW; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana., Rhodes SD; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.; Division of Pediatric Hematology-Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 01; Vol. 29 (17), pp. 3438-3456.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Neurofibroma, Plexiform*/etiology , Neurofibroma, Plexiform*/genetics , Neurofibromatosis 1*/drug therapy , Neurofibromatosis 1*/genetics , Nerve Sheath Neoplasms*/drug therapy , Nerve Sheath Neoplasms*/genetics , Neurofibroma*/complications, Humans ; Mice ; Animals ; MAP Kinase Signaling System ; Proteomics ; Protein Kinase Inhibitors/pharmacology ; Cyclin-Dependent Kinase 4/genetics
-
6دورية أكاديمية
المؤلفون: Sweeney CJ; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Percent IJ; Florida Cancer Specialists and Research Institute/Sarah Cannon Research Institute, Port Charlotte, Florida., Babu S; Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana., Cultrera JL; Florida Cancer Specialists/Sarah Cannon Research Institute, Leesburg, Florida., Mehlhaff BA; Oregon Urology Institute, Springfield, Oregon., Goodman OB; Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada., Morris DS; Urology Associates, PC, Nashville, Tennessee., Schnadig ID; Compass Oncology, Tualatin, Oregon., Albany C; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana., Shore ND; Carolina Urologic Research Center, Myrtle Beach, South Carolina., Sieber PR; Keystone Urology Specialists, Lancaster, Pennsylvania., Guba SC; Eli Lilly and Company, Indianapolis, Indiana., Zhang W; Eli Lilly and Company, Indianapolis, Indiana., Wacheck V; Eli Lilly and Company, Indianapolis, Indiana., Donoho GP; Eli Lilly and Company, Indianapolis, Indiana., Szpurka AM; Eli Lilly and Company, Indianapolis, Indiana., Callies S; Eli Lilly and Company, Indianapolis, Indiana., Lin BK; Eli Lilly and Company, Indianapolis, Indiana., Bendell JC; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee.
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jun 01; Vol. 28 (11), pp. 2237-2247.
نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/pathology, Benzamides ; Humans ; Male ; Nitriles/therapeutic use ; Phenylthiohydantoin/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Pyridines ; Quinolones ; Receptors, Androgen ; Treatment Outcome
-
7دورية أكاديمية
المؤلفون: Hong DS; The University of Texas MD Anderson Cancer Center, Houston, Texas. dshong@mdanderson.org., Moore KN; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Bendell JC; Sarah Cannon Research Institute, Nashville, Tennessee.; Tennessee Oncology, Nashville, Tennessee., Karp DD; The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang JS; Sarah Cannon Research Institute, Nashville, Tennessee.; Florida Cancer Specialists and Research Institute, Sarasota, Florida., Ulahannan SV; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Jones S; Sarah Cannon Research Institute, Nashville, Tennessee., Wu W; Eli Lilly and Company, Indianapolis, Indiana., Donoho GP; Eli Lilly and Company, Indianapolis, Indiana., Ding Y; Eli Lilly and Company, Indianapolis, Indiana., Capen A; Eli Lilly and Company, Indianapolis, Indiana., Wang X; Eli Lilly and Company, Indianapolis, Indiana., Bence Lin A; Eli Lilly and Company, Indianapolis, Indiana., Patel MR; Sarah Cannon Research Institute, Nashville, Tennessee.; Florida Cancer Specialists and Research Institute, Sarasota, Florida.
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Apr 01; Vol. 27 (7), pp. 1864-1874. Date of Electronic Publication: 2021 Jan 25.
نوع المنشور: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Protein Kinase Inhibitors/*administration & dosage , Pyrazines/*administration & dosage , Pyrazoles/*administration & dosage , Pyridines/*administration & dosage , Quinolones/*administration & dosage , Triple Negative Breast Neoplasms/*drug therapy, Adult ; Aged ; Animals ; Cell Line, Tumor ; Checkpoint Kinase 1/antagonists & inhibitors ; Female ; Humans ; MTOR Inhibitors/administration & dosage ; Male ; Mice ; Middle Aged ; Phosphoinositide-3 Kinase Inhibitors/administration & dosage ; Pyrazines/adverse effects ; Pyrazoles/adverse effects ; Pyridines/adverse effects ; Quinolones/adverse effects
-
8دورية أكاديمية
المؤلفون: Blosser WD; Eli Lilly and Company, Indianapolis, IN, USA., Dempsey JA; Eli Lilly and Company, Indianapolis, IN, USA., McNulty AM; Eli Lilly and Company, Indianapolis, IN, USA., Rao X; Eli Lilly and Company, Indianapolis, IN, USA., Ebert PJ; Eli Lilly and Company, Indianapolis, IN, USA., Lowery CD; Eli Lilly and Company, Indianapolis, IN, USA., Iversen PW; Eli Lilly and Company, Indianapolis, IN, USA., Webster YW; Eli Lilly and Company, Indianapolis, IN, USA., Donoho GP; Eli Lilly and Company, Indianapolis, IN, USA., Gong X; Eli Lilly and Company, Indianapolis, IN, USA., Merzoug FF; Eli Lilly and Company, Indianapolis, IN, USA., Buchanan S; Eli Lilly and Company, Indianapolis, IN, USA., Boehnke K; Eli Lilly and Company, New York, NY, USA., Yu C; Eli Lilly and Company, Shanghai, China., You XT; Eli Lilly and Company, Shanghai, China., Beckmann RP; Eli Lilly and Company, Indianapolis, IN, USA., Wu W; Eli Lilly and Company, Indianapolis, IN, USA., McNeely SC; Eli Lilly and Company, Indianapolis, IN, USA., Lin AB; Eli Lilly and Company, Indianapolis, IN, USA., Martinez R; Eli Lilly and Company, Indianapolis, IN, USA.
المصدر: Oncotarget [Oncotarget] 2020 Jan 21; Vol. 11 (3), pp. 216-236. Date of Electronic Publication: 2020 Jan 21 (Print Publication: 2020).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
-
9دورية أكاديمية
المؤلفون: Schaer DA; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Geeganage S; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Amaladas N; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Lu ZH; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Rasmussen ER; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Sonyi A; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Chin D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Capen A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Li Y; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Meyer CM; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Jones BD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Huang X; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Luo S; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Carpenito C; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Roth KD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Nikolayev A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Tan B; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Brahmachary M; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Chodavarapu K; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Dorsey FC; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Manro JR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Doman TN; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Donoho GP; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Surguladze D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Hall GE; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Kalos M; Lilly Research Laboratories, Eli Lilly and Company, New York, New York. ruslan.novosiadly@bms.com mkalos@arsenalbio.com., Novosiadly RD; Lilly Research Laboratories, Eli Lilly and Company, New York, New York. ruslan.novosiadly@bms.com mkalos@arsenalbio.com.
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Dec 01; Vol. 25 (23), pp. 7175-7188. Date of Electronic Publication: 2019 Aug 13.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*pharmacology , B7-H1 Antigen/*antagonists & inhibitors , Colonic Neoplasms/*drug therapy , Folic Acid/*metabolism , Immunotherapy/*methods , Lymphocyte Activation/*immunology , Mitochondria/*immunology, Animals ; Antineoplastic Agents, Immunological/pharmacology ; Apoptosis ; B7-H1 Antigen/immunology ; Cell Proliferation ; Colonic Neoplasms/immunology ; Colonic Neoplasms/metabolism ; Colonic Neoplasms/pathology ; Female ; Gene Expression Profiling ; Humans ; Lymphocyte Activation/drug effects ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mitochondria/drug effects ; Mitochondria/metabolism ; Mitochondria/pathology ; Oxygen Consumption ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
-
10دورية أكاديمية
المؤلفون: Du J; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana. du_jian@lilly.com., Yan L; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Torres R; Eli Lilly and Company, Alcobendas (Madrid), Spain., Gong X; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Bian H; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Marugán C; Eli Lilly and Company, Alcobendas (Madrid), Spain., Boehnke K; Eli Lilly and Company, Alcobendas (Madrid), Spain., Baquero C; Eli Lilly and Company, Alcobendas (Madrid), Spain., Hui YH; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Chapman SC; Eli Lilly and Company, Windlesham, United Kingdom., Yang Y; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Zeng Y; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Bogner SM; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Foreman RT; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Capen A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Donoho GP; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Van Horn RD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Barnard DS; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Dempsey JA; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Beckmann RP; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Marshall MS; Ped-Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Chio LC; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Qian Y; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Webster YW; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Aggarwal A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Chu S; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Bhattachar S; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Stancato LF; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Dowless MS; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Iversen PW; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Manro JR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Walgren JL; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Halstead BW; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Dieter MZ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Martinez R; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Bhagwat SV; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Kreklau EL; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Lallena MJ; Eli Lilly and Company, Alcobendas (Madrid), Spain., Ye XS; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Patel BKR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Reinhard C; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Plowman GD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Barda DA; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Henry JR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Buchanan SG; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Campbell RM; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2019 Dec; Vol. 18 (12), pp. 2207-2219. Date of Electronic Publication: 2019 Sep 17.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Aurora Kinase A/*antagonists & inhibitors , Mitosis/*drug effects, Antineoplastic Agents/pharmacology ; Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; Female ; HeLa Cells ; Humans ; Male